Immunotoxin Methods and Protocols by Walter A. HallImmunotoxin Methods and Protocols by Walter A. Hall

Immunotoxin Methods and Protocols

EditorWalter A. Hall

Paperback | November 10, 2010

Pricing and Purchase Info

$201.79 online 
$219.95 list price save 8%
Earn 1009 plum® points

In stock online

Ships free on orders over $25

Not available in stores

about

Hands-on experts from laboratories around the world describe in step-by-step detail their cutting-edge methods for developing and applying these powerful proteins. The conjugates created by these researchers contain entire monoclonal antibodies, single chain antibody fragments, and cytokines as their carrier ligands. Their toxic portion can include such conventional chemotherapeutics as doxirubicin, such ribosome-inactivating proteins the ricin A chain or saporin, or such bacterial toxins as diphtheria toxin. Also described are a variety of applications that demonstrate the versatility of these agents, including the treatment of primary malignant brain tumors, the generation of selective brain lesions to localize critical functions, and the targeting of the AIDS virus. Authoritative and highly practical, Immunotoxin Methods and Protocols provides today's cancer researchers, neuroscientists, and oncologists with state-of-the-art tools for exploring these powerful biological agents and their rapidly increasing applications.
Title:Immunotoxin Methods and ProtocolsFormat:PaperbackDimensions:320 pages, 9.02 × 5.98 × 0 inPublished:November 10, 2010Publisher:Humana PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1617371831

ISBN - 13:9781617371837

Look for similar items by category:

Customer Reviews of Immunotoxin Methods and Protocols

Reviews

Table of Contents

Part I. Immunotoxin Construction and Development. Development and Activities of the BR96-Doxorubicin Immunoconjugate, Ingegerd Hellström, Karl Erik Hellström, and Peter D. Senter. CD7-Specific Single Chain Fv Immunotoxins: Design and Expression, Christopher A. Pennell and Mary E. Pauza. Recombinant Fusion Toxins Directed Against the Human Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Receptor, Yu Shao, Berta E. Warman, and John P. Perentesis. Synthesis of Monensin Derivatives and Their Effect on the Activity of Ricin A-Chain Immunotoxins, Marco Colombatti and Franco Dosio. Purification and Conjugation of Type 1 Ribosome-Inactivating Proteins, Luigi Barbieri, Andrea Bolognesi, and Fiorenzo Stirpe. Comparison of Immunotoxins Bearing a Single Saporin Molecule with Multiple Toxin Conjugates, David J. Flavell and Sopsamorn U. Flavell. Modulation of Growth Factor Receptor Expression by Irradiation for Immunotoxin Targeting, Ki-Uk Kim, Hsaio-Tzu Ni, Stephen R. Spellman, Kwan H. Cho, Walter C. Low, and Walter A. Hall. Quantification of Immunotoxin Number for Complete Therapeutic Response, Robert J. Kreitman. In Vitro Studies of Ricin A-Chain-Induced Vascular Leak Syndrome, Alan L. Lindstrom and Christopher A. Pennell. Part II. Oncologic Applications of Immunotoxins. Immunotoxin Treatment of Brain Tumors, Walter A. Hall. Cytotoxins Directed at Interleukin-4 Receptors as Therapy for Human Brain Tumors, Raj K. Puri. Bispecific Monoclonal Antibodies for the Targeting of Type I Ribosome-Inactivating Proteins Against Hematological Malignancies, Silvano Ferrini, Sabrina Sforzini, and Silvana Canevari. Tyrosine Kinase Inhibitors Against EGF Receptor-Positive Malignancies, Elise A. Sudbeck, Sutapa Ghosh, Xing-Ping Liu, Yaguo Zheng, Dorothea E. Myers, and Fatih M. Uckun. Targeting Tumor Vasculature Using VEGF-Toxin Conjugates, S. Ramakrishnan, Robert Wild, and Dana Nojima. Gene Therapy with Immunotoxins, Daniel A. Vallera. Part III. Alternative Applications of Immunotoxins. Effects of Selective Immunotoxic Lesions on Learning and Memory, Mark G. Baxter. Targeting Toxins to Neural Antigens and Receptors, Ronald G. Wiley. In Vivo Testing of Anti-HIV Immunotoxins, Seth H. Pincus, Tamera K. Marcotte, Brent M. Forsyth, and Hua Fang. Index.